Search Results

LIXTE Biotechnology Holdings, Inc., a clinical stage pharmaceutical company, announced a collaboration with Roche and the Netherlands Cancer Institute to conduct a new clinical trial in immune therapy unresponsive metastatic colon cancer.

About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 diabetes program and looks to extend its cash runway.

Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, announced it has successfully completed 11 installs of its eProtein Discovery™ system, including at leading academic institutes.

LIXTE Biotechnology Holdings, Inc., a clinical stage pharmaceutical company, announced a collaboration with Roche and the Netherlands Cancer Institute to conduct a new clinical trial in immune therapy unresponsive metastatic colon cancer.

Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.

Vittorio Sebastiano , co-founder of Turn Biotechnologies will present at the prestigious Foresight Institute’s Longevity Frontiers Workshop today.

Anbio Biotechnology (“Anbio”), a leading global diagnostic solution provider, is excited to announce its participation in the ADLM 2024 Clinical Lab Expo (formerly the AACC Clinical Lab Expo).

Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.